Clofoctol inhibits sars-cov-2 replication and reduces lung pathology in mice

HIGHLIGHTS

• who: Sandrine Belouzard and collaborators from the Institut de, Plateformes lilloises en biologie et santu00e9, France, Univ, Inserm, Institut Editor: DMenachery, University of Texas have published the article: Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice, in the Journal: (JOURNAL) of May/19,/2022
• what: The authors report the high-throughput screening of ~2,000 drugs, approved for human use, for their potential activity against SARS-CoV-2. The authors demonstrate here that clofoctol treatment decreased the viral load in the lungs and drastically reduced pulmonary inflammation.
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.